Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Encapsulation of new biologically active peptides into liposomes and their immunoadjuvant effect (CROSBI ID 485277)

Prilog sa skupa u zborniku | izvorni znanstveni rad | međunarodna recenzija

Frkanec, Ruža ; Tomašić, Jelka ; Vranešić, Branka ; Halassy Špoljar, Beata ; Krstanović, Marina Encapsulation of new biologically active peptides into liposomes and their immunoadjuvant effect // Peptides 2002, Proceedings of the Twenty-Seventh European Peptide Symposium / Benedetti, Ettore ; Pedone, Carlo (ur.). Napulj: Edizioni Ziino, 2002. str. 490-491-x

Podaci o odgovornosti

Frkanec, Ruža ; Tomašić, Jelka ; Vranešić, Branka ; Halassy Špoljar, Beata ; Krstanović, Marina

engleski

Encapsulation of new biologically active peptides into liposomes and their immunoadjuvant effect

We have been examining the encapsulation of the new immunomodulators of peptidoglycan structure and synthetic adamantyltripeptides into the liposomes with the aim to possibly increase and optimize their therapeutic efficacy. Our studies concern two groups of immunomodulators: a) peptidoglycan monomer (PGM, GlcNAc-MurNAc-L-Ala-D-isoGln-mesoA2pm(eNH2)-D-Ala-D-Ala) and b) synthetic adamantyltripeptides (D- and L-(adamant-2-yl)-Gly-L-Ala-D-isoGln) comprising a part of peptidoglycan structure. All mentioned compounds were shown previously to exhibit immunostimulating activity1, 2. The immunostimulators tested were incorporated in large multilamellar negatively charged vesicles using egg lecithin and synthetic dipalmitoyl phosphatidylcholine (DPPC). The entrapment of tested compounds and the stability of the respective preparations were followed in two ways: by the use of 14C-labelled peptidoglycans or by HPLC. The immunoadjuvant activity was tested in vivo, in mice, using ovalbumin (OVA) as an antigen. The production of OVA-specific antibodies was monitored by ELISA. In comparison to the nonentrapped tested compounds the encapsulated preparations showed the better anti-OVA antibody production. Hence, incorporation of immunoadjuvants into liposomes improved their adjuvant activity. In conclusion, liposomes containing immunoadjuvants were prepared, quantity of incorporated material determined and the improved adjuvant effect of immunoadjuvants was demonstrated. 1. J. Tomašić, I. Hanzl-Dujmović, B. Špoljar, B. Vranešić, M. Šantak, A. Jovičić, Vaccine 8 (2000) 1236-1243. 2. B. Vranešić, J. Tomašić, S. Smerdel, D. Kantoci, F. Benedetti, Helv. Chim. Acta 76 (1993) 1752-1758.

liposomes; peptidoglycan monomer; adamantyltripeptides; adjuvants

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

490-491-x.

2002.

objavljeno

Podaci o matičnoj publikaciji

Peptides 2002, Proceedings of the Twenty-Seventh European Peptide Symposium

Benedetti, Ettore ; Pedone, Carlo

Napulj: Edizioni Ziino

Podaci o skupu

Twenty-Seventh European Peptides Symposium

poster

31.08.2002-06.09.2002

Sorrento, Italija

Povezanost rada

Kemija, Temeljne medicinske znanosti, Biologija